1[1]Avina-Zubieta J A, Galindo Rodriguez G, Newman S, et al. Long-term effectiveness of antimalarial drugs in rheumatic diseases[J]. Ann Rheum Dis, 1998,57(10):582-587.
2[2]Poole B, Ohkuma S. Effect of weak bases on the intralysosomal PH in mouse peritoneal macrophages[J]. J Cell Biol, 1981,90(3):665-669.
3[3]Van den Borne B E, Dijkmans B A, de Rooij H H, et al. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6,and interferon-gamma production by peripheral blood mononuclear cells[J]. J Rheumatol, 1997,24(1):55-60.
4[4]Lester R S, Burnham T K, Fine G, et al. Immunologic concepts of light reaction of lupus erythematosus and polymorphous light eruptions[J]. Arch Dermatol, 1967,96(1):1-10.
5[5]The HERA (Hydroxychloroquine in Early Rheumatoid Arthritis) Study Group. A randomized trial of hydroxychloroquine in early rheumatoid arthritis. The HERA Study[J]. Am J Med, 1995,98(2):156-168.
6[6]Fox R I, Dixon R, Guarrasi V, et al. Treatment of primary Sjogren's syndrome with hydroxychloroquine:a retrospective,open-label study[J]. Lupus, 1996,5 (suppl 1):s31-36.
7[7]Felson D T, Anderson J J, Meenan R F, et al. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis[J]. Arthritis Rheum, 1990,33(10):1449-1961.
8[8]Van der Heijde D M, van Riel P L, Nuver-Zwart I H, et al. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis[J]. Lancet, 1989,1(8646):1036-1038.
9[9]Bunch T W, O'Duffy J D, Tompkins R B, et al. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis[J]. Arthritis Rheum, 1984,27(3):267-276.
10[10]Landewe R B M, Goei The H S, Van Rijthove A M, et al. A randomized double-blind 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis[J]. Arthritis Rheum, 1994,37(5):637-643.
